RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/29217135http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/29217135http://www.w3.org/2000/01/rdf-schema#comment"Venous thromboembolism (VTE), the third leading cardiovascular complication, requires more understanding at molecular levels. Here, we have identified miR-145 as a key molecule for regulating thrombus formation in venous thrombosis (VT) employing network based bioinformatics approach and in vivo experiments. Levels of miR-145 showed an inverse correlation with thrombus load determined by coagulation variables. MiRNA target prediction tools and in vitro study identified tissue factor (TF) as a target gene for miR-145. The restoration of miR-145 levels in thrombotic animals via in vivo miR-145 mimic delivery resulted in decreased TF level and activity, accompanied by reduced thrombogenesis. MiR-145 levels were also reduced in VT patients and correlated with increased TF levels in patients, thereby, confirming our preclinical findings. Our study identifies a previously undescribed role of miRNA in VT by regulating TF expression. Therefore, restoration of miR-145 levels may serve as a promising therapeutic strategy for management of VT."xsd:string
http://purl.uniprot.org/citations/29217135http://purl.org/dc/terms/identifier"doi:10.1016/j.ebiom.2017.11.022"xsd:string
http://purl.uniprot.org/citations/29217135http://purl.uniprot.org/core/author"Sharma S."xsd:string
http://purl.uniprot.org/citations/29217135http://purl.uniprot.org/core/author"Singh S."xsd:string
http://purl.uniprot.org/citations/29217135http://purl.uniprot.org/core/author"Gupta N."xsd:string
http://purl.uniprot.org/citations/29217135http://purl.uniprot.org/core/author"Prabhakar A."xsd:string
http://purl.uniprot.org/citations/29217135http://purl.uniprot.org/core/author"Tyagi T."xsd:string
http://purl.uniprot.org/citations/29217135http://purl.uniprot.org/core/author"Nair V."xsd:string
http://purl.uniprot.org/citations/29217135http://purl.uniprot.org/core/author"Goel S."xsd:string
http://purl.uniprot.org/citations/29217135http://purl.uniprot.org/core/author"Sahu A."xsd:string
http://purl.uniprot.org/citations/29217135http://purl.uniprot.org/core/author"Kumari B."xsd:string
http://purl.uniprot.org/citations/29217135http://purl.uniprot.org/core/author"Chatterjee T."xsd:string
http://purl.uniprot.org/citations/29217135http://purl.uniprot.org/core/author"Jha P.K."xsd:string
http://purl.uniprot.org/citations/29217135http://purl.uniprot.org/core/author"Ashraf M.Z."xsd:string
http://purl.uniprot.org/citations/29217135http://purl.uniprot.org/core/author"Singh H.D."xsd:string
http://purl.uniprot.org/citations/29217135http://purl.uniprot.org/core/date"2017"xsd:gYear
http://purl.uniprot.org/citations/29217135http://purl.uniprot.org/core/name"EBioMedicine"xsd:string
http://purl.uniprot.org/citations/29217135http://purl.uniprot.org/core/pages"175-186"xsd:string
http://purl.uniprot.org/citations/29217135http://purl.uniprot.org/core/title"MicroRNA-145 Impedes Thrombus Formation via Targeting Tissue Factor in Venous Thrombosis."xsd:string
http://purl.uniprot.org/citations/29217135http://purl.uniprot.org/core/volume"26"xsd:string
http://purl.uniprot.org/citations/29217135http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/29217135
http://purl.uniprot.org/citations/29217135http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/29217135
http://purl.uniprot.org/uniprot/#_B2R6M5-mappedCitation-29217135http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/29217135
http://purl.uniprot.org/uniprot/#_P13726-mappedCitation-29217135http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/29217135